Benitec Biopharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Benitec Biopharma Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2019 to Q2 2024.
  • Benitec Biopharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $20.6M, a 6.06% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $20.6M -$1.33M -6.06% Jun 30, 2024 10-K 2024-09-26
Q2 2023 $21.9M +$3.96M +22% Jun 30, 2023 10-K 2024-09-26
Q2 2022 $18M +$1.74M +10.7% Jun 30, 2022 10-K 2023-09-21
Q2 2021 $16.2M +$2.93M +22.1% Jun 30, 2021 10-K 2022-09-02
Q2 2020 $13.3M +$2.22M +20% Jun 30, 2020 10-K 2021-09-20
Q2 2019 $11.1M Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.